US2010216743A1PendingUtilityA1

Therapy-enhancing glucan

Assignee: SLOAN KETTERING INST CANCERPriority: Jul 16, 2003Filed: Apr 26, 2010Published: Aug 26, 2010
Est. expiryJul 16, 2023(expired)· nominal 20-yr term from priority
A61K 47/36A61K 31/715A61K 39/39541A61K 39/39A61K 39/44A61P 43/00A61K 31/716A61P 37/04A61K 2039/55583C08B 37/0024A61K 39/39558A61P 35/00A61K 31/739
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides a method for introducing substances into cells comprising contacting a composition comprising orally administered beta-glucan with said cells. This invention also provides a method for introducing substances into a subject comprising administering to the subject an effective amount of the above compositions. The substance which could be delivered orally includes but is not limited to peptides, proteins, RNAs, DNAs, chemotherapeutic agents, biologically active agents, plasmids, and other small molecules and compounds. Finally, this invention provides a composition comprising orally administered beta-glucan capable of enhancing efficacy of IgM and different uses of the said composition.

Claims

exact text as granted — not AI-modified
1 . A composition for oral uptake of substance comprising an appropriate amount of carbohydrates. 
     
     
         2 . A composition for the oral delivery of one or more substances comprising an effective amount of an orally administered beta-glucan and one or more chemotherapeutic agents. 
     
     
         3 - 13 . (canceled)

Join the waitlist — get patent alerts

Track US2010216743A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.